Cargando…

Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence

The COVID-19 pandemic has encouraged the repurposing of existing drugs as a shorter development strategy in order to support clinicians with this difficult therapeutic dilemma. There is evidence to support the theory that some antidepressants can reduce concentrations of different cytokines in human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mas, Marta, García-Vicente, Juan Antonio, Estrada-Gelonch, Anaïs, Pérez-Mañá, Clara, Papaseit, Esther, Torrens, Marta, Farré, Magí
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319396/ https://www.ncbi.nlm.nih.gov/pubmed/35887802 http://dx.doi.org/10.3390/jcm11144038

Ejemplares similares

Drug Interactions With New Synthetic Opioids
por: Pérez-Mañá, Clara, et al.
Publicado: (2018)

Acute Pharmacological Effects of 2C-B in Humans: An Observational Study
por: Papaseit, Esther, et al.
Publicado: (2018)

Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis
por: Torres-Moreno, Mari Carmen, et al.
Publicado: (2018)

Soy Isoflavone Extract Does Not Increase the Intoxicating Effects of Acute Alcohol Ingestion in Human Volunteers
por: Martínez-Riera, Roser, et al.
Publicado: (2019)

Cannabinoids: from pot to lab
por: Papaseit, Esther, et al.
Publicado: (2018)

Acute Pharmacological Effects of Oral and Intranasal Mephedrone: An Observational Study in Humans
por: Papaseit, Esther, et al.
Publicado: (2021)

BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression
por: Fonseca, Francina, et al.
Publicado: (2022)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2020)

Interaction of Energy Drinks with Prescription Medication and Drugs of Abuse
por: Hladun, Olga, et al.
Publicado: (2021)

A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure
por: Poyatos, Lourdes, et al.
Publicado: (2021)

Abuse Potential of Cathinones in Humans: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2022)

New Psychoactive Substances Consumption in Opioid-Use Disorder Patients
por: Alías-Ferri, Maria, et al.
Publicado: (2022)

Synthetic cannabinoids use in a sample of opioid-use disorder patients
por: Alías-Ferri, María, et al.
Publicado: (2022)

Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders
por: García-Marchena, Nuria, et al.
Publicado: (2019)

Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions
por: González, Débora, et al.
Publicado: (2015)

Acute Effects of 2C-E in Humans: An Observational Study
por: Papaseit, Esther, et al.
Publicado: (2020)

The Tryptophan System in Cocaine-Induced Depression
por: Fonseca, Francina, et al.
Publicado: (2020)

Bilastine vs. hydroxyzine: occupation of brain histamine H(1)-receptors evaluated by positron emission tomography in healthy volunteers
por: Farré, Magí, et al.
Publicado: (2014)

Mephedrone and Alcohol Interactions in Humans
por: Papaseit, Esther, et al.
Publicado: (2020)

Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH
por: Sprega, Giorgia, et al.
Publicado: (2023)

Pharmacological effects of methylone and MDMA in humans
por: Poyatos, Lourdes, et al.
Publicado: (2023)

UHPLC-HRMS and GC-MS Screening of a Selection of Synthetic Cannabinoids and Metabolites in Urine of Consumers
por: Pellegrini, Manuela, et al.
Publicado: (2020)

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
por: Busardò, Francesco Paolo, et al.
Publicado: (2021)

Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS
por: La Maida, Nunzia, et al.
Publicado: (2020)

Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study
por: Martínez, Lucia, et al.
Publicado: (2021)

Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries
por: Fonseca, Francina, et al.
Publicado: (2021)

Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials
por: Fuentes, Juan José, et al.
Publicado: (2020)

Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users
por: Maida, Nunzia La, et al.
Publicado: (2021)

Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans
por: Poyatos, Lourdes, et al.
Publicado: (2022)

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
por: Pérez-Acevedo, Ana Pilar, et al.
Publicado: (2020)

GC–MS/MS Determination of Synthetic Cathinones: 4-chloromethcathinone, N-ethyl Pentedrone, and N-ethyl Hexedrone in Oral Fluid and Sweat of Consumers under Controlled Administration: Pilot Study
por: Nuñez-Montero, Melani, et al.
Publicado: (2023)

Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry and High-Sensitivity Gas Chromatography-Mass Spectrometry Screening of Classic Drugs and New Psychoactive Substances and Metabolites in Urine of Consumers
por: Marchei, Emilia, et al.
Publicado: (2021)

Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity
por: Rodríguez-Morató, Jose, et al.
Publicado: (2019)

Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans
por: Di Giorgi, Alessandro, et al.
Publicado: (2023)

Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
por: Pardo-Lozano, Ricardo, et al.
Publicado: (2012)

Exclusion of NFAT5 from Mitotic Chromatin Resets Its Nucleo-Cytoplasmic Distribution in Interphase
por: Estrada-Gelonch, Anaïs, et al.
Publicado: (2009)

Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study
por: Sanvisens, Arantza, et al.
Publicado: (2021)

Contribution of Cytochrome P450 and ABCB1 Genetic Variability on Methadone Pharmacokinetics, Dose Requirements, and Response
por: Fonseca, Francina, et al.
Publicado: (2011)

Hair analysis following chronic smoked-drugs-of-abuse exposure in adults and their toddler: a case report
por: Papaseit, Esther, et al.
Publicado: (2011)

Dual Depression: A Sex Perspective
por: Farré, Adriana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_87cd2rl9r66biumecoraoit7vv